APA (7th ed.) Citation

Leon, R., Diez-Domingo, J., Andrews, C., Cunha, C. A. d., Choo, E., Hui, D. S. C., . . . McNeil, S. A. (2026). Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5–6 Years After Primary Vaccination in Adults ≥50 Years. Open Forum Infectious Diseases, 13(6), 1. https://doi.org/10.1093/ofid/ofag282

Chicago Style (17th ed.) Citation

Leon, Rafael, et al. "Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5–6 Years After Primary Vaccination in Adults ≥50 Years." Open Forum Infectious Diseases 13, no. 6 (2026): 1. https://doi.org/10.1093/ofid/ofag282.

MLA (9th ed.) Citation

Leon, Rafael, et al. "Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5–6 Years After Primary Vaccination in Adults ≥50 Years." Open Forum Infectious Diseases, vol. 13, no. 6, 2026, p. 1, https://doi.org/10.1093/ofid/ofag282.